FR2323381A1 - Amidrazones vinylogues, procede pour leur preparation et medicaments les contenant - Google Patents

Amidrazones vinylogues, procede pour leur preparation et medicaments les contenant

Info

Publication number
FR2323381A1
FR2323381A1 FR7627217A FR7627217A FR2323381A1 FR 2323381 A1 FR2323381 A1 FR 2323381A1 FR 7627217 A FR7627217 A FR 7627217A FR 7627217 A FR7627217 A FR 7627217A FR 2323381 A1 FR2323381 A1 FR 2323381A1
Authority
FR
France
Prior art keywords
hydrazones
opt
substd
acroleins
corresp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7627217A
Other languages
English (en)
French (fr)
Inventor
Hermann Amschler
Wolfgang Schoetensack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU73350A external-priority patent/LU73350A1/xx
Priority claimed from LU75301A external-priority patent/LU75301A1/xx
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of FR2323381A1 publication Critical patent/FR2323381A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7627217A 1975-09-09 1976-09-09 Amidrazones vinylogues, procede pour leur preparation et medicaments les contenant Withdrawn FR2323381A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU73350A LU73350A1 (de) 1975-09-09 1975-09-09
LU75301A LU75301A1 (de) 1976-07-05 1976-07-05

Publications (1)

Publication Number Publication Date
FR2323381A1 true FR2323381A1 (fr) 1977-04-08

Family

ID=26640189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7627217A Withdrawn FR2323381A1 (fr) 1975-09-09 1976-09-09 Amidrazones vinylogues, procede pour leur preparation et medicaments les contenant

Country Status (5)

Country Link
JP (1) JPS5262282A (de)
DE (1) DE2640186A1 (de)
DK (1) DK405576A (de)
FR (1) FR2323381A1 (de)
NL (1) NL7609941A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113788762A (zh) * 2021-08-13 2021-12-14 京博农化科技有限公司 一种采用固定床反应器制备3-二正丙胺基丙烯醛的方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113788762A (zh) * 2021-08-13 2021-12-14 京博农化科技有限公司 一种采用固定床反应器制备3-二正丙胺基丙烯醛的方法
CN113788762B (zh) * 2021-08-13 2024-06-07 山东京博农化科技股份有限公司 一种采用固定床反应器制备3-二正丙胺基丙烯醛的方法

Also Published As

Publication number Publication date
NL7609941A (nl) 1977-03-11
JPS5262282A (en) 1977-05-23
DK405576A (da) 1977-03-10
DE2640186A1 (de) 1977-03-24

Similar Documents

Publication Publication Date Title
IE792524L (en) Azabicycloalkyl derivatives.
AR241414A1 (es) Procedimiento para la preparacion de derivados de 2,2'-iminobisetanol y obtencion de intermediarios.
ES344357A1 (es) Un procedimiento para preparar ciclopropanocarboxilatos.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
ES433148A1 (es) Procedimiento para preparar derivados de pirazol.
FR2323381A1 (fr) Amidrazones vinylogues, procede pour leur preparation et medicaments les contenant
NO151620C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme, nye pyrrolyl-3-pyridazinaminer
GB1342558A (en) Substituted 3-benzylpyridines
OA06585A (fr) Dérivés triazonyl-alcéniques, leur procédé de production et leur utilisation comme fongicides.
SE7704615L (sv) Sett att framstella nya 1,4-bensodioxanderivat
FI844940A0 (fi) 1,5-bensoxatiepinderivat, deras framstaellning och anvaendning.
ES428673A1 (es) Procedimiento para la obtencion de derivados de nitrobenzo-fenona sustituidos.
GB1447329A (en) Preparation of sulphonyl-benzamide derivatives
NO823647L (no) Fremgangsmaate ved fremstilling av nye imidazolcarboxylsyrederivater.
FR2313064A1 (fr) Derives de l'(indenyloxymethyl)-2-morpholine
FR2230349A1 (en) 1-Phenyl-2-methyl-5-methoxy indoles - with e.g. sedative, cardiac analeptic, vasodilator, antihypertensive, analgesic, and antiinflammatory activities
ES426771A1 (es) Procedimiento para preparar derivados aminopropanolicos.
NO830399L (no) Fremgangsmaate ved fremstilling av nye carbacycliner
FR2279383A1 (fr) Nouveaux derives tetrasubstitues des alcoylene-diamines, leurs sels, leur preparation et les medicaments qui en contiennent
GB1358451A (en) Polyisocyanates processes for their manufacture and their use
SE7709487L (sv) Elektropleteringsbad
FR2259589A1 (en) 2-Acylamino-chromones - with cardiac stimulant, analgesic and antiinflammatory, and some with normolipaemic activity
FI810714L (fi) Nya 1-(acylamino-aryloxi-)2-hydroxi-3-alkinylaminopropaner och foerfarande foer deras framstaellning
FR2215223A1 (en) 6-morpholinomethyl-1,3-oxazines - with analgesic, hypotensive, analeptic, anticonvulsant, anxiolytic, antidepressant, vasodilator activities etc.
GB1492236A (en) Di-hydroethanoanthracene derivatives

Legal Events

Date Code Title Description
ST Notification of lapse